Executive Director
CurrentOver 30 years of leadership and research experience with focus on Formulation development and Analytical characterization of various dosage forms for regulated markets. The expertise includes niche technologies i.e. Parenterals, Ophthalmics, Complex injectables, reverse engineering and In-vitro release studies